TransMedics Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89377M1099
USD
138.63
-3.14 (-2.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
TransMedics Group, Inc.
iRhythm Technologies, Inc.
AtriCure, Inc.
ICU Medical, Inc.
LivaNova Plc
Integer Holdings Corp.
Axonics, Inc.
CONMED Corp.
InMode Ltd.
Pacific Biosciences of California, Inc.
STAAR Surgical Co.
Why is TransMedics Group, Inc. ?
1
With a growth in Net Profit of 186.26%, the company declared Outstanding results in Jun 25
  • The company has declared positive results for the last 12 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 115.27 MM
  • ROCE(HY) Highest at 28.21%
  • INVENTORY TURNOVER RATIO(HY) Highest at 4.89 times
2
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
3
Market Beating performance in long term as well as near term
  • Along with generating 85.80% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to TransMedics Group, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is TransMedics Group, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
TransMedics Group, Inc.
94.05%
0.01
63.90%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
85.51%
EBIT Growth (5y)
34.54%
EBIT to Interest (avg)
-3.78
Debt to EBITDA (avg)
1.84
Net Debt to Equity (avg)
0.76
Sales to Capital Employed (avg)
0.48
Tax Ratio
2.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.06%
ROE (avg)
5.81%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
96
Industry P/E
Price to Book Value
17.67
EV to EBIT
93.44
EV to EBITDA
66.22
EV to Capital Employed
10.46
EV to Sales
10.05
PEG Ratio
0.53
Dividend Yield
NA
ROCE (Latest)
11.20%
ROE (Latest)
18.38%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

36What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 115.27 MM

ROCE(HY)

Highest at 28.21%

INVENTORY TURNOVER RATIO(HY)

Highest at 4.89 times

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -1.34% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 5.71 times

NET SALES(Q)

Highest at USD 157.37 MM

OPERATING PROFIT(Q)

Highest at USD 43.3 MM

OPERATING PROFIT MARGIN(Q)

Highest at 27.51 %

PRE-TAX PROFIT(Q)

Highest at USD 36.18 MM

NET PROFIT(Q)

Highest at USD 34.91 MM

EPS(Q)

Highest at USD 0.92

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for TransMedics Group, Inc.
Operating Cash Flow
Highest at USD 115.27 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit
At USD 36.18 MM has Grown at 197.72%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 34.91 MM has Grown at 186.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 4.89 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales
Highest at USD 157.37 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 157.37 MM has Grown at 37.68%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 43.3 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 27.51 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 36.18 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 34.91 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.92
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio
Highest at 5.71 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -1.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 6.73 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)